Introduction
The injectisome allows pathogenic or symbiotic bacteria to inject effector proteins across eukaryotic cell membranes, a process called type III secretion (T3S). It is evolutionary related to the bacterial flagellum (reviewed by Macnab (2003) ). Both structures share a similar basal body consisting of several rings embedded in the two bacterial membranes connected by a central rod (Blocker et al, 1999 (Blocker et al, , 2001 Marlovits et al, 2004; Morita-Ishihara et al, 2006) . Depending on the family of injectisomes, a hollow stiff needle (Kubori et al, 1998 (Kubori et al, , 2000 Blocker et al, 1999 Blocker et al, , 2001 Hoiczyk and Blobel, 2001 ), a filament (Knutton et al, 1998; Daniell et al, 2001; Crepin et al, 2005) or a pilus (Van Gijsegem et al, 2000) terminate the structure. The length of the needle is genetically determined (Magdalena et al, 2002; Tamano et al, 2002; Journet et al, 2003) .
The proximal rings are thought to contain the T3S export apparatus, made of a number of integral membrane proteins and soluble components (reviewed by Tampakaki et al (2004) ; Cornelis (2006) ; Galan and Wolf-Watz (2006) ). In the Yersinia Ysc injectisome, a ca 60-nm long stiff hollow needle, assembled from the 9-kDa protein YscF, projects from the basal body into the exterior milieu (Hoiczyk and Blobel, 2001 ). The needle terminates in a tip structure (the tip complex) made of the protein LcrV (Mueller et al, 2005) . Upon contact with a eukaryotic cell membrane, the injectisome translocates a set of proteins called Yops (reviewed by ). These include the translocators (YopB and YopD) that form a pore in the target membrane and the effectors that traffic through this pore. The tip complex is thought to act as a scaffold for the folding and assembly of YopB and YopD into a functional pore (Goure et al, 2005) .
During morphogenesis, the components of the transmembrane rings are handled by the Sec machinery, while those of the rod and the needle are sequentially exported by the T3S apparatus itself (Sukhan et al, 2001) , traveling through the growing structure and polymerizing at its distal end (Li et al, 2002) . There is no clear hierarchy in the synthesis of the components. Thus, the export apparatus is expected to switch its substrate specificity over time from early to late substrates, so that needle subunits (early substrates) are exported before LcrV and before the Yops (late substrates). This substrate specificity switch presumably leads to the arrest of needle growth, which determines the needle length. Hence, it is only triggered when the needle has reached its genetically defined length. The trigger is provided by YscP, another early substrate of the export apparatus. The N-terminal sequence of YscP is thought to act as a molecular ruler , while the C-terminal domain triggers the substrate specificity switch (Agrain et al, 2005a) .
Mutations affecting FliK, the flagellar YscP homolog, lead to extra-long hooks (called polyhooks) but no filament and hence bacteria are not motile (Hirano et al, 1994) . Motile revertants appear as consequence of extragenic suppressive mutations in the integral membrane protein FlhB, suggesting that FlhB is involved in specificity switching (Kutsukake et al, 1994; Williams et al, 1996) . FlhB has a long C-terminal cytosolic domain, which undergoes an autoproteolytic cleavage between N269 and P270; however, the resulting subdomains remain tightly associated with each other (Minamino and Macnab, 2000; Fraser et al, 2003; Ferris et al, 2005) . This cleavage is abolished by the mutation N269A and cells producing FlhB N269A assemble polyhook structures lacking filaments, leading to the proposal that cleavage and interaction of the two fragments generates conformational changes important for the specificity switching process (reviewed by Ferris and Minamino (2006) ).
The FlhB homolog in the Yersinia injectisome is YscU, a 354-residue polypeptide with four transmembrane helices and a long cytoplasmic tail (Allaoui et al, 1994) (Figure 1A ). Like FlhB, YscU undergoes autoproteolytic cleavage before P264, generating a 10-kDa C-terminal fragment (Lavander et al, 2002) . YscU N263A is not cleaved at this site, but nevertheless retains the capacity to secrete Yops (Lavander et al, 2002) .
The position of LcrV, at the tip of the needle, implies that LcrV is exported immediately after YscF but before the Yops. Thus, the hierarchy must consist of at least three categories of substrates and not two as in the flagellum; however, to date there are no genetic data to support this assumption. In this paper, we show that YscU N263A is impaired in the export of the translocators LcrV, YopB and YopD but not in the export of the effector Yops. Accordingly, cells with YscU N263A produce needles without tip complexes and this effect can be assigned to a lack of LcrV recognition. Thus, YscU is specifically involved in substrate recognition and has to be cleaved to acquire the conformation required for translocator recognition. This is the first genetic evidence that translocators represent an individual category of substrates in the hierarchy of export. Accordingly, the translocators, and not the Yop effectors, occupy the same rank as flagellin in the assembly of the flagellum.
Results

Mutation of residue N263 or P264 changes the autocleavage properties of YscU
To analyze the phenotype of a non-cleavable YscU mutant, we generated different point mutations in the NPTH motif of YscU and overexpressed the resulting yscU N263A , yscU P264A and yscU T265A genes in trans in Y. enterocolitica DyscU mutant bacteria. The yscU wt gene and the mutated alleles were overexpressed from the pBAD promoter only at the end of the logarithmic growth phase when synthesis of the T3S system was induced by shifting to 371C. In those conditions, we did not observe any clear toxicity of either the YscU wt or the mutated YscU, as reported by others (Lavander et al, 2002) . This discrepancy presumably results from differences in the experimental conditions used in the two reports. It is indeed likely that early overexpression of an integral membrane protein is toxic.
We then analyzed YscU in membranes purified from the different Y. enterocolitica strains incubated in secretion permissive conditions by immunoblotting with anti-YscU antibodies ( Figure 1B ). In strains expressing yscU or yscU T265A , an YscU fragment of about 10 kDa was clearly detectable. This could be assigned to the C-terminal part (CC) after cleavage at or around the NPTH motif. In contrast no 10-kDa fragment was present in bacteria expressing yscU N263A or yscU P264A . Here, a protein fragment of about 16 kDa (indicated as CC*), probably resulting from cleavage at an alternative site, was observed, as already shown for an yscU DNPTH mutant from Y. pseudotuberculosis (Lavander et al, 2002) . This 16-kDa fragment was also present in lower amounts in membranes of strains expressing yscU wt or yscU T265A . The 24-kDa N-terminal part (TM þ CN*) remaining after cleavage at this alternative site was detected in all YscU expressing strains. The cleavage at or around the NPTH motif, which results in the C-terminal 10-kDa (CC) fragment described above, would leave a 30-kDa N-terminal fragment (TM þ CN). This 30-kDa fragment was not only found in strains overexpressing yscU wt or yscU T265A that contained the small 10-kDa fragment, but also in samples from bacteria overexpressing yscU N263A or yscU P264A , where we did not observe the 10-kDa fragment. Furthermore, uncleaved YscU wt (TM þ CN þ CC) could be detected in all bacterial samples expressing yscU, demonstrating that cleavage was never complete. The data presented in Figure 1 are representative of a number of highly reproducible experiments.
Up to now, due to detection problems the cleavage of YscU and its flagellar homolog FlhB has only been demonstrated after overexpression of the protein (above and Minamino and Macnab, 2000; Lavander et al, 2002) . We also analyzed the cleavage of wild-type (wt) amounts of YscU wt . As shown in Figure 1C , the 10-kDa (CC) and the 30-kDa (TM þ CN) fragments of YscU wt could be detected in purified membranes. In addition, we observed cleavage at the alternative site, resulting in the 24-kDa (TM þ CN*) and the 16-kDa (CC*) fragments, as shown for overproduced YscU wt ( Figure 1B , lane 2 and Figure 1C , lane 4). We then analyzed Strains and plasmids used: wt (pYV40); DyscU (pLY4001); yscU N263A , mutation inserted at the yscU locus (pISO4007); yscU
a mutant expressing yscU N263A from its native promoter on the virulence plasmid of Y. enterocolitica. In agreement with the data obtained after overproduction of YscU N263A , a 30-kDa protein was present in the membranes from yscU N263A mutant bacteria, suggesting cleavage at or around the NPTH motif, but again no 10-kDa fragment co-purified. In addition, the 24-kDa signal corresponding to the N-terminal part after cleavage at the alternative site was present. Importantly, the uncleaved YscU protein was always detected at 40 kDa (TM þ CN þ CC), demonstrating that even when expressed at natural levels, YscU cleavage was not complete. These data thus confirm the data obtained with the overexpressed protein presented above. Together, they suggest that YscU is cleaved at least at two different sites. Although the 10-kDa fragment only co-purifies with the remaining N-terminal part in strains producing YscU wt or YscU T265A , it does not formally rule out that the first cleavage occurs in YscU N263A or YscU P264A , because the sequence alteration could prevent the binding of the cleaved 10-kDa fragment. In contrast, the Cterminal 16-kDa fragment produced by the cleavage at the alternative site co-purifies with its N-terminal half, even in strains producing YscU N263A or YscU P264A . Although the data are not quantitative, they show that a preferred point of cleavage exists, which depends on the protein examined.
yscU N263A and yscU P264A mutants export effector Yops but no translocators Next we tested whether export of Yop proteins was affected in the different yscU mutants. To do this, the yop regulon was induced in the different Y. enterocolitica strains and the culture supernatants were analyzed by SDS-PAGE and Coomassie staining. In agreement with previously reported data, no Yops were secreted by DyscP and DyscU mutant bacteria (Allaoui et al, 1994; Stainier et al, 2000) , and the yscU T265A mutant showed the same pattern of exported proteins as the wt ( Figure 2A ). In contrast, the yscU N263A and yscU P264A mutant bacteria did not export translocators ( Figure 2A ). The defect in translocator export was not due to overexpression of yscU N263A , since expression of yscU N263A from its native promoter had the same effect ( Figure 2A ). Analysis of YopE and LcrV in culture supernatants by immunoblotting confirmed this result ( Figure 2B ). The intrabacterial levels of YopE and LcrV were comparable in wt and yscU N263A mutant bacteria. Whereas the export of YopE in yscU N263A mutant bacteria was only slightly decreased compared to the wt, no exported LcrV could be detected ( Figure 2B ). To check whether overexpression of lcrV in an yscU N263A mutant background could overcome the lack of export, as previously shown for export compromised yscP mutants (Agrain et al, 2005b) , lcrV was overexpressed from the pBAD promoter by adding varying concentrations of Larabinose ( Figure 2C ). Only on maximal lcrV overexpression with 0.5% L-arabinose a faint LcrV band could be observed in the supernatant fraction of yscU N263A mutant bacteria ( Figure 2C ). Overexpression of lcrV in wt Yersinia did not change the export level, possibly because the export capacity of the wt was already saturated.
The yscU N263A mutant does not assemble a tip complex and fails to induce lysis in red blood cells
The fact that the yscU N263A mutant did not export the translocators LcrV, YopB and YopD suggests that this mutant may not be able to form the translocation pore. Formation of the translocation pore can be studied by infection of red blood cells (RBCs), which undergo hemolysis (Hakansson et al, 1996) . Since Y. enterocolitica bacteria do not adhere to RBCs, a DyopN mutant that secretes Yops in a contactindependent manner has been used previously (Marenne et al, 2003) . Therefore, a DyopNyscU N263A mutant was generated. As expected from the DyopN deletion, secretion of Yops by the DyopNyscU N263A mutant was independent of the presence of calcium, whereas secretion of Yops by the yscU N263A mutant and wt bacteria was calcium dependent (data not shown). The pattern of proteins secreted by the DyopNyscU N263A mutant was identical to that of proteins secreted by the yscU N263A mutant, except that YopN was missing ( Figure 3B ). We analyzed the capacity of the DyopNyscU N263A mutant to concentrations ranging from 0.02 to 0.5% were used to induce LcrV synthesis when bacteria were shifted to 371C and again 2 h later. TC and SN were analyzed by immunoblotting using anti-LcrV antibodies. Strains and plasmids used: wt (pYV40); DyscP (pLJ4036);
induce lysis in RBCs. In agreement with the loss of translocator export, lytic activity was neither observed for the DyopNyscU N263A mutant nor for the negative control DHOPEMNV mutant lacking LcrV ( Figure 3C ). Like for wt, and DyopN mutant bacteria, needles could be observed on the surface of DyopNyscU N263A mutant bacteria ( Figure 3A ). The needles from yscU N263A mutant bacteria were purified and analyzed by scanning transmission electron microscopy (STEM) ( Figure 3D ). Out of 51 needles analyzed, none had a tip and 16 had a clear pointed end ( Figure 3D ), as previously reported for the lcrV mutant (Mueller et al, 2005) . These data confirm the defect in the export of LcrV.
The impaired export of LcrV is due to a lack of recognition by the YscU N263A protein There might be at least two reasons why LcrV is not exported in the yscU N263A mutant; either LcrV is not recognized by the YscU N263A protein or the YscU N263A protein has an altered conformation, which blocks the export channel for some substrates. To investigate if the channel is still permissive for LcrV, we fused the export signal of the effector YopE to the N-terminus of LcrV and analyzed the export of the hybrid protein in the yscU N263A mutant. As shown in Figure 4A , a protein of the expected size was detected by Coomassiestained SDS-PAGE of the supernatant fraction. The identity of the protein was confirmed by immunoblot using anti-LcrV antibodies ( Figure 4B ). In contrast to the YopE-hybrid protein, LcrV alone was not exported in the yscU N263A mutant. These data suggest that the loss of LcrV export in the yscU N263A mutant is not due to changes of the channel properties, but rather due to a defect in recognition of LcrV as export substrate. We then wondered whether the YopE 1À15 LcrV hybrid protein would be functional in the yscU N263A mutant, that is, whether this protein would be able to form a functional tip complex. We first investigated the functionality of the hybrid protein in an lcrV mutant (here DHOPEMNV), by testing its ability to induce lysis of RBCs. The multi-effector mutant DHOPEMN was used as positive control and induced 46% hemolysis, whereas the lcrV mutant DHOPEMNV only led to 1% hemolysis ( Figure 4C ). Overexpression of either lcrV or yopE 1À15 lcrV in lcrV mutant bacteria could restore hemolysis up to wt level, indicating that the hybrid protein was functional ( Figure 4C ). As expected, expression of yopE 1À15 lcrV in the DyopNyscU N263A mutant could not restore the lytic activity, because not only LcrV but also the two other translocators YopB and YopD were not exported by this mutant ( Figure 4C ). When purified needles of an yscU N263A mutant expressing yopE 1À15 lcrV were analyzed using STEM, tip complexes were detected on 43 out of 76 analyzed needles ( Figure 4D ). This shows that LcrV export by yscU N263A mutant bacteria could be restored by using the export signal of YopE. Furthermore, the yopE 1À15 lcrV fusion resulted in a functional protein that was able to form a tip complex. From these data we cannot say that not all the needles have a tip, because we can never exclude that some needles analyzed broke during purification.
Needles of Yersinia yscU N263A and yscU P264A mutants are longer and less regulated Next, we were interested in whether the different yscU mutations described above would affect the length of the injectisome needle. Therefore, needles from Y. enterocolitica DyscU bacteria overexpressing yscU, yscU N263A , yscU P264A or yscU T265A were measured. Needles of yscU T265A mutant bacteria had wt length (yscU wt : median 61715 nm; yscU T265A : median 63715 nm), whereas needles from bacteria overexpressing yscU N263A or yscU P264A were longer and less controlled than the wt (yscU N263A : median 107751 nm; yscU P264A : median 119753 nm) (Supplementary Figure S1) . These data reflect the differences that we reported above for the cleavage of YscU and the export of the translocators.
Needle length in a yscU N263A mutant is still controlled by YscP
To analyze whether YscP still exerts its ruler function in a yscU N263A mutant, we combined yscP alleles of different sizes with the yscU N263A allele. As shown before , yscU wt bacteria producing the 388-amino acid ruler YscP 388 made shorter needles (4977 nm), whereas bacteria producing the 680-amino acid ruler yscP 680 made longer needles (149745 nm) than yscU wt bacteria endowed with the wt ruler yscP 515 (67711 nm) ( Figure 5A , histograms I-III). 
yscU N263A mutant bacteria producing the different YscP proteins made longer needles than yscU wt bacteria. Length still correlated with the number of residues of YscP, but the control was not as tight, as shown by the larger standard deviations (yscU N263A yscP 388 : 91nm763 nm; yscU N263A yscP 515 : 111743 nm; yscU N263 yscP 680 : 222796 nm) ( Figure 5A , histograms IV-VI). By plotting the medians of needle length against the number of amino acids in YscP, we obtained parallel slopes for the yscU wt and the yscU N263A mutant ( Figure 5D ). In addition to these changes in needle length, yscU N263A mutant bacteria exported less YscP than wt bacteria ( Figure 5B and C) . The increase in needle length as well as the decrease in length control could be due to this decrease in YscP export, as shown previously (Agrain et al, 2005b) . We therefore tested whether an increase in YscP production would compensate the defects in length control. Therefore, yscP 388 , yscP 515 and yscP 680 were overexpressed from the pBAD promoter in yscU N263A mutant bacteria harboring the corresponding yscP allele on the virulence plasmid. Overproduction of the different YscP proteins increased their export to wt level, as shown by immunoblot analysis of the total cell and supernatant fractions using anti-YscP antibodies ( Figure 5C ). Increased production of YscP 388 , YscP 515 and YscP 680 in yscU N263A mutant bacteria ( Figure 5A , histograms VII-IX) led to needles that were comparable to those of the corresponding yscU wt strains ( Figure 5A , histograms X-XII). Although yscU N263A mutant bacteria overexpressing yscP had needles of the expected length ( Figure 5A , histogram VIII), they still did not export translocators (Supplementary Figure S2) .
The plot in Figure 5E shows that overexpression of YscP can indeed restore needle length control in the yscU N263A shown. Strains and plasmids used: wt (pYV40); yscP 388 (pLJ4022); yscP 515 (pYV40); yscP 680 (pLJM4001); yscU N263A yscP 388 (pISO4011); yscU N263A yscP 515 (pISO4007); yscU N263A yscP 680 (pISO4012); yscU N263A and yscP 388 þ þ þ (pISO4011 þ pCA20); yscU N263A and yscP 515 þ þ þ (pISO4007 þ pLJ6); yscU N263A and yscP 680 þ þ þ (pISO4012 þ pLJ19); yscU wt and yscP 388 þ þ þ (pLJ4022 þ pCA20); yscU wt and yscP 515
mutant to wt level. This showed that the defect in needle length control of the yscU N263A mutant was rather due to a failure in YscP export than to a failure of the substrate specificity switch.
Discussion
The fact that the injectisome exports its own distal components, before it exports the effectors, implies that the T3S apparatus can recognize and sequentially export different categories of substrates. To achieve this, it is believed to switch its substrate specificity when assembly is completed. To better understand this sequential export process, we introduced mutations into the NPTH cleavage site of YscU and analyzed the phenotypes. At variance with previous reports on FlhB (Minamino and Macnab, 2000) and YscU (Lavander et al, 2002) , we not only analyzed the phenotype after overexpression of cloned yscU alleles, but also after replacement of the yscU alleles on the pYV plasmid, ensuring physiological expression levels. To detect minute protein quantities, we probed the proteins with an anti-YscU antiserum rather than an antibody directed against the C-terminus or a C-terminal His-tag. Our results confirmed that the 40-kDa YscU is naturally cleaved into a TM þ CN 30-kDa fragment and a 10-kDa CC fragment, as shown previously for FlhB (Minamino and Macnab, 2000) and for YscU from Y. pseudotuberculosis (Lavander et al, 2002) . In good agreement with the estimated stoichiometry of two FlhB molecules per flagellum (Zhu et al, 2002) , unless overexpressed, the CC product from YscU could only be detected after enrichment by purification of the membrane fraction from Y. enterocolitica. Surprisingly, the cleavage of YscU was never complete, even at physiological expression levels, although bacteria were harvested at a stage where all the needles analyzed had their normal length and tip complex. No CC fragment was detected for the mutant proteins YscU N269A and YscU P264A , as shown before by Lavander et al (2003) using C-terminal tagged YscU. As pointed out by these authors, this suggests that cleavage did not occur. However, since a band corresponding to the size of the TM þ CN fragment was still observed, we cannot formally rule out that cleavage was prevented. We observed an alternative cleavage site in the YscU N269A and YscU P264A mutant proteins, yielding a ca 24-kDa (TM þ CN*) and a ca 16-kDa (CC*) fragment. This alternative cleavage of YscU is reminiscent of the alternative cleavage observed in FlhB N269A and FlhB P270A , but was not reported for YscU from Y. pseudotuberculosis. Surprisingly, we detected the TM þ CN* fragment in extracts from bacteria producing YscU wt , suggesting that even YscU wt could be partially cleaved at this alternative cleavage site.
The yscU N263A mutant bacteria assembled injectisome needles, but their length seemed to be poorly controlled and the median length was 111 nm rather than the 67 nm found for wt bacteria. When this yscU N263A allele was combined with a longer (680 codons) and a shorter (388 codons) allele of yscP, the median needle lengths were 222 nm and 91 nm, respectively, indicating that needle length was still dependent on the length of the YscP ruler, although the standard deviation was much larger. In addition to this loose length control, the yscU N263A bacteria released less YscP into the culture supernatant than wt bacteria do, although the intra-bacterial amount of protein was unchanged. We tried to overcome the poor export efficiency of YscP by overexpressing the gene downstream from the pBAD promoter. As expected from the previous work of Agrain et al (2005b) , overexpression of the three different yscP alleles indeed led to the export of more YscP proteins, and also to a better control of needle length. The latter was in fact as good as in yscU wt bacteria. Hence, we conclude that the yscU N263A mutation reduces the efficacy of the T3S system to export YscP, which, indirectly, leads to a less stringent control of needle length. We also conclude that the yscU N263A mutation does not affect the capacity of the T3S export apparatus to switch off the export of the YscF needle subunits when the needle reaches its genetically defined length.
These data demonstrate that the cleavage at the NPTH motif is not required to switch off needle subunit export. Even more, they confirm that the same variants of YscU and YscP can give rise to two different needle lengths, depending on the amount of YscP exported. To us, this rules out the hypothesis that YscU could play a role as a timer to determine needle length, as was proposed for the flagellar hook length control (Moriya et al, 2006) . yscU N263A mutant bacteria also released slightly less effector Yops than wt bacteria, but the export of effectors was still significant. This observation shows that the export machine is still capable of switching on the export of Yops. Hence, the yscU N263A mutation does not affect the substrate specificity switching from early (YscF, YscP) to late (Yops) substrates. This interpretation agrees with the observations reported by Lavander et al (2002) that mutation yscU N263A does not affect Yop secretion in Y. pseudotuberculosis. However, it may seem at odds with the observation that mutation flhB N269A prevents export of flagellin, and with the interpretation that it inhibits the substrate specificity switch.
The most intriguing phenotype of the yscU N263A mutation was the deficiency in export of the translocators LcrV, YopB and YopD. In good agreement with the fact that LcrV was not exported, needles produced by the mutant bacteria had no tip complex.
A deficiency in translocator export is not completely unprecedented. The invE mutant of Salmonella enterica showed reduced secretion of the translocators SipB, SipC and SipD, while the export of other T3S effectors was increased (Kubori and Galan, 2002) . Beside these observations and the fact that InvE is not required for the assembly of the needle complex, nothing is known about the actual function of InvE and its putative homologs. Mutants sepL and sepD, mutants of enteropathogenic and enterohemorrhagic Escherichia coli, as well as of Citrobacter rodentium, have a similar phenotype; translocator secretion is completely abolished, while the export of effector proteins is increased (Deng et al, 2005) . It was suggested that SepL and SepD are not only necessary for efficient translocator secretion but also control a switch from translocator to effector secretion by sensing certain environmental signals such as low calcium (Deng et al, 2005) . A yscW (called earlier virG) mutant of Y. enterocolitica also shows a decrease in the amounts of secreted proteins, especially of the translocators YopB, YopD and LcrV (Allaoui et al, 1995) . YscW is the pilot protein of the secretin YscC (Burghout et al, 2004) and hence its absence probably modifies the channel properties.
Here, the failure to export LcrV and to assemble the needle tip could be circumvented by the N-terminal addition of the YopE export signal to LcrV. This indicates that the failure to export LcrV was not due to a change in the channel conformation, making it unsuitable for protein export, but rather to a failure in substrate recognition. This implies that the translocators have a specific type of export signal and a status distinct from the effectors regarding export. This makes sense, since they need to be exported before the effectors (Cornelis and Wolf-Watz, 1997) . We already know that LcrV is exported before the Yops, since it forms the tip complex, even in the absence of Yop secretion (Mueller et al, 2005) . However, no mutation specifically affecting export of the effectors has been described before. Surprisingly, while considerable effort was made to unravel the export signal of YopE (Michiels and Cornelis, 1991; Sory et al, 1995; Anderson and Schneewind, 1997) , YopH (Michiels and Cornelis, 1991; Sory et al, 1995) , YopN (Anderson and Schneewind, 1997) and YopQ (Michiels and Cornelis, 1991; Anderson and Schneewind, 1999) in Yersinia, little has been done to decipher the signal of translocators. It is known that LcrV can be exported even with an N-terminal His-tag, and that both the N-and C-termini of LcrV are required for its export (Fields et al, 1999) . This can be taken as a hint that the signals are different for effectors and translocators, although more work is needed to characterize the export signals of the translocators and hence to understand the hierarchy of assembly. The export signal of YscP, an early substrate, was recently characterized and turned out to be totally different from the known export signal of effectors (Agrain et al, 2005b) .
As mentioned above, the phenotype of the yscU N263A mutation may appear, at first sight, to be different from the phenotype of the flhB N269A mutation, in the sense that YscU N263A allows Yop (late substrate) export, while FlhB N269A does not allow flagellin export. However, the two observations can easily be reconciled, given the additional observation that YscU N263A prevents export of the translocators. Keeping in mind that there are two hierarchy classes in the assembly of the flagellum (hook/rod and filament) and three hierarchy classes in the operation of the injectisome (needle, translocators, effectors), both mutants are simply deficient in the export of the second hierarchy class.
Finally, our results confirm that YscU, and especially the structure of the CC fragment, plays a critical role in substrate recognition. They also show that the translocators are specifically recognized by YscU and thus, the injectisome has at least three classes of substrates. However, they do not provide any evidence that cleavage of the CC fragment is involved in the substrate specificity switch.
(2 h/150 000 g/41C). The pellet containing the total cell membranes was resuspended in 400 ml buffer I. Lipids were extracted with 400 ml n-hexan for 30 min/41C on a rotating wheel. After isolation of the lower hydrophilic phase, proteins were precipitated by addition of four volumes acetone (1 h/41C), centrifuged (10 min/20À800 g/ 41C) and resuspended in 160 ml buffer II (7 M urea, 2 M thiourea, 2% CHAPS), and supplemented with 40 ml 5 Â SDS loading buffer (5 Â SDS loading buffer: 225 mM Tris-HCl, pH 6.8, 5% SDS, 50% glycerol, 50 mM DTT, bromophenol blue). Samples were separated on a 15% SDS-PAGE, transferred onto nitrocellulose membrane and analyzed by immunoblotting with anti-YscU antibodies.
YscU antibodies
To produce polyclonal anti-YscU antibodies (MIPA 221), YscU 211À354 was expressed from the pBAD promoter with a C-terminal His-tag, using plasmid pLY1. A soluble His-protein was produced in E. coli Top10 and purified on chelating sepharose beads (Amersham Biosciences). A rabbit was immunized by four injections with a total of 1 mg of YscU 211À354 (CER, Marloie, Belgium). For immunoblot analysis, anti-YscU antibodies were used at a dilution of 1:1000.
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Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
